Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
293 questions in 51 reviews · ENT
current versionsNo studies 293 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Beta‐blockers vs placebo Improvement in vertigo · people with vestibular migraine Pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Calcium channel blockers vs no intervention Serious adverse events · people with vestibular migraine Pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
SSRIs and SNRIs vs placebo or no treatment Improvement in vertigo at 6 to ≤ 12 months · adults with PPPD Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
SSRIs and SNRIs vs placebo or no treatment Change in vertigo at 6 to ≤ 12 months · adults with PPPD Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
SSRIs and SNRIs vs placebo or no treatment Serious adverse events · adults with PPPD Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs non‐surgical treatment Disease‐specific quality of life · children aged 6 months to 12 years with OME Ventilation tubes (grommets) for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs non‐surgical treatment Presence/persistence of OME · children aged 6 months to 12 years with OME Ventilation tubes (grommets) for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs myringotomy Disease‐specific quality of life · children aged 6 months to 12 years with OME Ventilation tubes (grommets) for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs no treatment Disease‐specific quality of life · children aged 6 months to 12 years with OME Ventilation tubes (grommets) for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Early ventilation tubes vs watchful waiting (treatment later if required) Disease‐specific quality of life · children aged 6 months to 12 years with OME Ventilation tubes (grommets) for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Abundant water intake vs no treatment Change in vertigo · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Abundant water intake vs no treatment Serious adverse events · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Sleeping in darkness vs no treatment Change in vertigo · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Sleeping in darkness vs no treatment Serious adverse events · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Specially processed cereals vs placebo Improvement in vertigo · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Specially processed cereals vs placebo Change in vertigo · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Specially processed cereals vs placebo Serious adverse events · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Intratympanic gentamicin vs no treatment/placebo Serious adverse events · Ménière’s disease Intratympanic gentamicin for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Positive pressure therapy vs placebo Serious adverse events · adults with Ménière’s disease Positive pressure therapy for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs no treatment Change in frequency of vertigo · Ménière’s disease Surgical interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs no treatment Serious adverse events · Ménière’s disease Surgical interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Endolymphatic sac decompression vs placebo (sham surgery) Serious adverse events · adults with Ménière’s disease Surgical interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and unilateral ventilation tube vs unilateral ventilation tube only Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and unilateral ventilation tube vs unilateral ventilation tube only Adverse event: haemorrhage · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and ventilation tubes vs no treatment/watchful waiting Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy (with or without myringotomy) vs no treatment/watchful waiting Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and bilateral ventilation tubes vs bilateral ventilation tubes only Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo Disease‐specific quality of life · children (aged 6 months to 12 years) with otitis media with effusion (OME) Antibiotics for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Disease‐specific quality of life · children (aged 6 months to 12 years) with otitis media with effusion (OME) Antibiotics for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Topical (intranasal) steroids vs no treatment Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Topical (intranasal) steroids vs no treatment Adverse event: systemic corticosteroid side effects · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral steroids vs no treatment Hearing · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral steroids vs no treatment Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Dietary intervention (probiotics) vs placebo Improvement in vertigo · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs no treatment Serious adverse effects · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Dietary intervention (probiotics) vs placebo Serious adverse events · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy (CBT) vs no treatment Improvement in vertigo · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy (CBT) vs no treatment Serious adverse events · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs no treatment Improvement in vertigo · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Triptans vs placebo Change in vertigo · adults with acute attacks of vestibular migraine Pharmacological interventions for acute attacks of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Transcranial direct current stimulation vs placebo Improvement in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs placebo or no treatment Serious adverse events · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs placebo or no treatment CI: confidence interval · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Transcranial direct current stimulation vs placebo Change in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment Improvement in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment Change in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment Serious adverse events · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment CI: confidence interval · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs placebo or no treatment Improvement in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs placebo or no treatment Change in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |